PKY Secures Paradigm Contract & Expands Trial Capabilities

Summary by 6ix AI

The agreement, valued at a specified amount, will involve assessing the trial's design and analysis to identify potential reasons for interim findings. This engagement highlights TrialKey's expanded capabilities in clinical trial design and optimization, utilizing machine-learning models for predictive insights. The contract represents a significant step in TrialKey's commercial application of its services within the biotech sector.

Written by 6ix AI from the company’s filing. How 6ix writes summaries